 Inhibited autoxidation assay

An inhibited autoxidation assay measures how an added substance changes the time course of a substrate's autoxidation under specified conditions. A radical-trapping antioxidant competes with radical chain propagation, so both the speed of interception and the amount of trapping capacity can affect the observed curve. A smaller oxidation rate and a longer delay before rapid oxidation are distinct observations.

An experiment compares a defined oxidizable substrate with and without the test substance, using matched solvent, temperature, oxygen availability and radical chain initiation. The readout must track the oxidation process rather than merely the test substance's own optical background. One primary method uses a visible-light spectrophotometer and a BODIPY-based signal carrier that co-autoxidizes with a hydrocarbon substrate.^[ref] The instrument observes a probe response; interpreting it as substrate oxidation requires the method's coupled-reaction model.

An original limiting model explains an autoxidation inhibition period. Let radical-chain initiation supply chains at constant concentration rate $R_i$. Suppose the antioxidant initially has concentration $C_{A0}$ and can intercept $n$ chain carriers per molecule, with fast, nearly quantitative interception until it is exhausted. Capacity balance givesFor chosen values $C_{A0}=10\mu \mathrm{M}$, $n=2$ and $R_i=0.10\mu \mathrm{M}{\mathrm{s}}^{-1}$, the modeled period is $200\mathrm{s}$. Doubling the antioxidant concentration doubles it under these assumptions. But $n=4$ at $5\mu \mathrm{M}$ gives the same capacity, so an inhibition period alone does not separately determine trapping stoichiometry and antioxidant concentration.

Autoxidation initiation-rate calibration is consequently part of the inference. If initiation varies between samples, a longer inhibition period need not mean more antioxidant. Finite trapping rates, side reactions, inhibitor regeneration and changing oxygen availability can invalidate the simple capacity model. Comparing the inhibited slope with the uninhibited curve asks a kinetic question in addition to the capacity question.

A 1983 primary study used inhibited autoxidation to estimate lipid-soluble chain-breaking antioxidant concentrations in human plasma and erythrocyte ghosts, and compared those results with vitamin E measured by high-performance liquid chromatography.^[ref] That independent comparison tests a relationship between activity and composition in the studied preparations; an arbitrary antioxidant-assay signal alone does not establish chemical identity or a health benefit.